Cargando…
Apixaban therapy in a pregnant woman with heparin-induced thrombocytopenia and venous thromboembolic events caused by congenital antithrombin deficiency: A case report
We report the case of a 35-year-old pregnant woman (gravida 3, para 1) with antithrombin deficiency who was successfully treated with apixaban. She had a history of heparin-induced thrombocytopenia and venous thromboembolic events. Pregnancy was confirmed while the patient was having anticoagulant t...
Autores principales: | Komori, Mayuko, Hayata, Eijiro, Nakata, Masahiko, Yuzawa, Hitomi, Oji, Ayako, Morita, Mineto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152699/ https://www.ncbi.nlm.nih.gov/pubmed/32300539 http://dx.doi.org/10.1016/j.crwh.2020.e00200 |
Ejemplares similares
-
iPREFACE score: Integrated score index to predict fetal acidemia by intrapartum fetal heart rate monitoring
por: Ito, Ayumu, et al.
Publicado: (2021) -
Time trend analysis of perinatal mortality, stillbirth, and early neonatal mortality of multiple pregnancies for each gestational week from the year 2000 to 2019: A population-based study in Japan
por: Hayata, Eijiro, et al.
Publicado: (2022) -
The Role of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia
por: Khalid, Sidra, et al.
Publicado: (2017) -
Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
por: Larsen, Pia Bükmann, et al.
Publicado: (2015) -
Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
Publicado: (2020)